Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/17582802

Cancer 2007 Aug 15 110 4 791-800

Download in:

View as

General Info

PMID
17582802